By Dr Mark Alastair Boyd

Journal articles

Boyd MA; Aarnoutse RE; Ruxrungtham K; Stek M; van Heeswijk RP; Lange JM; Cooper DA; Phanuphak P; Burger DM, 2003, 'Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects', Journal of Acquired Immune Deficiency Syndrome, 34, pp. 134 - 139

Law WP; Dore GJ; Duncombe CJ; Mahanontharit A; Boyd MA; Ruxrungtham K; Lange JM; Phanuphak P; Cooper DA, 2003, 'Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001', AIDS, 17, pp. 2191 - 2199

Conference Papers

Lau A; Kong F; Fairley C; Templeton D; Amin J; Phillips S; Law M; Chen M; Bradshaw C; Donovan B; McNulty A; Boyd M; Timms P; Chow E; Regan D; Khaw C; Lewis D; Kaldor J; Ratnayake M; Carvalho N; Hocking J, 2021, 'O11.2 Treatment efficacy of 1g azithromycin versus 100mg doxycycline bi-daily for seven days for asymptomatic rectal Chlamydia trachomatis', in STI treatment, BMJ Publishing Group Ltd, pp. A40.2 - A40, presented at Abstracts for the STI & HIV World Congress, July 14–17 2021, http://dx.doi.org/10.1136/sextrans-2021-sti.111

Khaw C; Raw L; Zablotska-Manos I; Boyd M, 2018, 'Chemsex: prevalence, characteristics and associated risk profiles of men who have sex with men in South Australia. A cross-sectional cohort study', in HIV MEDICINE, WILEY, pp. S46 - S46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430174700122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gartner C; Boyd M; Bonevski B; Gilks C; Borland R; Courtney R; Cobiac L; McRobbie H; Baker P; Mueller J, 2018, 'CESSATION AND RELAPSE PREVENTION TRIAL: VAPORISED NICOTINE PRODUCTS FOR PEOPLE ON OPIATE SUBSTITUTION THERAPY, OR WHO ARE LIVING WITH HEPATITIS C OR HIV', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S6 - S6

Holt SG; Gracey DM; Mudge DW; Irish AB; Sevastos J; Walker RG; Baer RA; Levy MT; Boyd MA, 2014, 'RENAL FUNCTION TESTING IN PATIENTS ON TENOFOVIR ANTIVIRAL THERAPY', in NEPHROLOGY, WILEY-BLACKWELL, pp. 72 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Achhra AC; Boyd M; Law MG; Matthews G; Kelleher AD; Cooper DA, 2013, 'Sequencing antiretroviral therapy to maximize patient safety: could we move away from ritonavir, abacavir, tenofovir and efavirenz (RATE) - agents that concern prescribers and patients? A feasibility study and call for a trial', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, BELGIUM, Brussels, pp. A51 - A51, presented at 15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, BELGIUM, Brussels, 15 October 2013 - 17 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335230200056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chadwick M; Boyd MA; Cathers B, 1997, 'A water quality modelling tutorial using SIMULINK', in MODSIM 1997: International Congress on Modelling and Simulation, University of Tasmania, Hobart, presented at MODSIM 1997: International Congress on Modelling and Simulation, University of Tasmania, Hobart, 08 December 1997 - 11 December 1997

Boyd MA; Cathers B; Chadwick M; Craig E, 1996, 'Developing a set of teaching exercises in ennvironmental engineering modelling', in 8th Australasian Association for Engineering Education Conference and Convention, University of New South Wales, presented at 8th Australasian Association for Engineering Education Conference and Convention, University of New South Wales, 15 December 1996 - 18 December 1996

Preprints

Karran EL; Chiarotto A; Cashin AG; Sharma S; Barker T; Boyd M; Maxwell L; Mohabir V; Petkovic J; Tugwell P; Moseley GL, 2025, ‘Identifying Social Factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in Pain Research’: Explanation and elaboration to support the standardised reporting of equity-relevant data, http://dx.doi.org/10.31219/osf.io/hm52q_v1

Karran EL; Cashin AG; Sharma S; Chiarotto A; Barker T; Boyd M; Maxwell L; Mohabir V; Petkovic J; Tugwell P; Moseley GL, 2025, Identifying Social factors that Stratify Health Opportunities and Outcomes (ISSHOOs) in pain research: Consensus recommendations for the collection and reporting of equity-relevant data, http://dx.doi.org/10.31219/osf.io/z29bk_v1

Neadley KE; Downes M; Chan L; Poirier B; Lynch J; Boyd M; Shoubridge C, 2025, A Health Navigator intervention to address the unmet social needs of caregivers of hospitalised children in South Australia: protocol for a mixed-methods pilot study, http://dx.doi.org/10.1101/2025.03.24.25324580

Neadley K; Shoubridge C; Smith A; Martin S; Boyd M; Hocking C, 2024, Addressing unmet social needs using a health navigator for patients at a major metropolitan hospital in Australia: a mixed-methods feasibility study, http://dx.doi.org/10.1101/2024.04.02.24305238

Shoubridge C; Maddison J; Lynch J; Boyd M, 2024, Profiling health and socioeconomic disadvantage in the northern Adelaide Local Health Network population, http://dx.doi.org/10.1101/2024.01.02.24300748

Stretton B; Kovoor JG; Gupta AK; Ovenden C; Litwin P; Maddern GJ; Boyd M, 2022, Making up for Lost Time: Perioperative Direct Oral Anticoagulant Assay Measurements, http://dx.doi.org/10.22541/au.166723035.55498329/v1

Back to profile page